Profile picture

Doctor Alberto Giannoni

Sant'Anna School of Advanced Studies, Pisa (Italy)
Membership: FESC Member
Follow
Biography
I am Assistant Professor at Scuola Superiore Sant’Anna (SSSA), Pisa, Italy and Consultant Cardiologist at the Cardiology and Cardiovascular Medicine Division, at Fondazione Toscana Gabriele Monasterio (FTGM), Pisa, Italy, a Research Hospital set up in collaboration with the Italian National Research Council and the Tuscany Regional Health System. My current clinical interests cover the spectrum of medical management of cardiovascular diseases, in particular coronary heart disease, myopathies and cardiomyopathies, heart failure (HF) and arrhythmias, with a focus on juvenile sudden death. Since ever, my research activity has been characterized by a translational approach and has focused on brain-heart interactions and on the neuroendocrine control of cardiovascular and respiratory function in health and disease, namely in HF, with particular attention to the study of pathophysiology of visceral feed-backs, such as chemoreflex, baroreflex and ergoreflex, and central apneas.
Logo ESC

Contributor content

Effects of SGLT2i on right ventricule function in HFpEF: an echocardiographic study
Presentation
Effects of SGLT2i on right ventricule function in HFpEF: an echocardiographic study
A miniaturized cooling system for trans-esophageal echocardiographic probes may improve patients safety in minimally invasive cardiac surgery or trans-catheter percutaneous interventions
Presentation
A miniaturized cooling system for trans-esophageal echocardiographic probes may improve patients safety in minimally invasive cardiac surgery or trans-catheter percutaneous interventions
Prognostic impact of echocardiographic derived precapillary wedge pressure and pulmonary vascular resistances in patients with heart failure
Presentation
Prognostic impact of echocardiographic derived precapillary wedge pressure and pulmonary vascular resistances in patients with heart failure
Clinical and prognostic significance of left ventricular outflow tract velocity time integral (LVOT-VTI) in patients with chronic heart failure
Presentation
Clinical and prognostic significance of left ventricular outflow tract velocity time integral (LVOT-VTI) in patients with chronic heart failure
Haemodynamic forces as predictors of cardiac remodelling and outcome in heart failure with reduced ejection fraction treated with sacubitril/valsartan
Presentation
Haemodynamic forces as predictors of cardiac remodelling and outcome in heart failure with reduced ejection fraction treated with sacubitril/valsartan
Chemoreflex and baroreflex dysfunction still predict cardiovascular mortality and hospitalizations in patients with systolic heart failure and up-to-date treatment
Presentation
Chemoreflex and baroreflex dysfunction still predict cardiovascular mortality and hospitalizations in patients with systolic heart failure and up-to-date treatment
Central apneas and Ticagrelor related dyspnea in patients with acute coronary syndrome
Presentation
Central apneas and Ticagrelor related dyspnea in patients with acute coronary syndrome
Benefit of buspirone on chemoreflex and  central apneas in heart failure
Presentation
Benefit of buspirone on chemoreflex and central apneas in heart failure
CMR in heart failure: detecting inflammation and fibrosis.
Presentation
CMR in heart failure: detecting inflammation and fibrosis.
Plant Gain, Chemoreflex Gain, Circulation Time and Cheyne-Stokes Respiration in Heart Failure
Presentation
Plant Gain, Chemoreflex Gain, Circulation Time and Cheyne-Stokes Respiration in Heart Failure

ESC 365 is supported by